Frost.com - Connected Health Research http://www.frost.com/c/10260/home.do - Connected Health Research Thu, 24 May 2018 9:05:14 Breakthrough Innovations in PoC Diagnostics for Smart Healthcare http://www.frost.com/prod/servlet/sublib/display-report.do?id=D817-01-00-00-00 Today, the healthcare industry is focused toward patient centric care and preventative healthcare. Preventative healthcare involves regular screening and diagnosis for diseases before the condition becomes fatal. Early diagnosis improves the clinical outcome of the patients, reduces emergency visits, and subsequently healthcare costs. Usually, early diagnosis is enabled by point-of-care testing (POCT) devices, where physicians or even the patients can check themselves for various conditions and monitor their chronic diseases, at the point-of-care, bringing healthcare services closer to the patients. This research service showcases the trends and applications of POCT devices. The growing importance and benefits of the POC devices are discussed in this research service. This research service focuses on the technology innovations of blood glucose POCT, POC infectious disease diagnosis, POC cancer screening, and POC neurological screening. This research service focuses on technology innovations, key innovators in this space, industry trends, drivers and challenges, and its market impact. Wed, 2 May 2018 00:00:00 +0100 Global Digital Health Maternal and Infant Care Solutions Market Leaders, Innovators, and Startups, 2018 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MDEA-01-00-00-00 BabyTech (digital tools targeted at infants/toddlers) and FemTech (digital solutions for helping women with their health issues) are the latest trends in the healthcare industry. Digital health tools are finding applications in all areas of parenting fertility, pregnancy, birthing, nursing, baby health, and safety. Women form nearly half the population and are the key decision makers at home. Public health concerns such as rising pre-term births and maternal mortality rates are strong factors that are encouraging consumers, healthcare providers and other stakeholders to use digital health solutions to better manage the entire birth continuum, from conception, to birth, and during the first years of infant care. Many factors are driving increased focus from key healthcare stakeholders paving the way for more innovative and targeted digital health solutions. Regulatory bodies and the investment community both realize the potential and applications of digital health tools in this space and have been willing to give it the focus it truly deserves. However, lack of awareness of these tools and their advantages among women and healthcare providers, lack of clear reimbursement policies, accuracy and data security/privacy are factors that need to be addressed by companies in this area. The maternal and infant care space continues to evolve along with major technology and health trends; this is creating a dynamic and exciting area for both vendors and users of these offerings. Moving forward, companies will look at increasingly integrating AI capabilities to yield optimal utility from data in a progressive way as well as leveraging Virtual Assistants as part of user-platform experiences, paving way for non-healthcare companies such as Amazon, Google and others to become key participants in this market. More companies will create products to form a connected home ecosystem the Smart Nursery; these products are interoperable devices that can be managed from the user s smartphone. Frost & Sullivan also expects to see more companies investing in clinical studies,which aim to validate the accuracy of digital health applications in this area as part of further validation, and needed data to support potential claims or other business model aspirations. This report identifies the movers and shakers (companies-2-action) in the maternal and infant care market for digital health, namely, innovative and visionary companies that are creating the market and shaping its trends and growth opportunities moving forward.--BEGIN PROMO--

Key Issues Addressed

  • What are the current digital health opportunities in the maternal and infant care space?
  • Which unique companies are introducing new and innovative solutions?
  • How are connected home progressions impacting the healthcare market in this area?
  • How will AI play a role in maternal and infant care technology?
  • What are the key success factors in this market?
Wed, 2 May 2018 00:00:00 +0100
2018 Top Technologies in Medical Devices & Imaging http://www.frost.com/prod/servlet/sublib/display-report.do?id=D821-01-00-00-00 TechVision's Medical Devices and Imaging technology cluster's flagship research service profiles ten cutting-edge medical technologies that are expected to have a huge impact on the healthcare industry in the next two years. Each of technologies that have been profiled here represent billions of dollars in market potential, and have a rich track record of R&D funding, intellectual property (IP) activity and a vibrant innovation ecosystem. Each of the technology profiles covers the following: Brief technology snapshot, breadth of applications, key innovations and innovators, five-year market potential, recent funding and business deals, important market factors aiding and hindering growth. This list includes technologies that are just seeing the light of commercialization, as well as those technologies that are already in the market, but are expected to make an impact through wide-spread adoption. This research service is a product of a year-long scout of the MedTech industry and other adjacent innovation clusters. This report aims to provide a snapshot of the top medical technologies, serving as a strategic guide to innovators and senior management, helping companies in innovation planning and decision-making. Mon, 30 Apr 2018 00:00:00 +0100 2018 Top Technologies in Health & Wellness http://www.frost.com/prod/servlet/sublib/display-report.do?id=D80A-01-00-00-00 TechVision s annual Top 10 Health and Wellness Technologies research delivers cutting-edge insights about the 10 most valuable and disruptive technologies poised to impact global healthcare industry in the next 18 months. The chosen 10 technologies have the highest innovation index and were selected using a proprietary methodology based on several criteria, such as industry adoption, IP activity, funding, and market potential among others. These hottest technologies pack maximum potential to fuel global innovation, spawn innovative products, and drive commercial growth. This comprehensive research offers strategic guidance and actionable ideas to executives in innovation-focused organizations. Mon, 30 Apr 2018 00:00:00 +0100 Global Hospital-based Medical Device Connectivity Market, Forecast to 2022 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MBB7-01-00-00-00 For the last few years, healthcare providers globally have been focusing on implementing Electronic Medical Record (EMR) systems and fine-tuning workflow and functionalities to best suit end-user needs. In many countries, the implementation of EMRs has seen high adoption and has been quite successful. It is widely accepted that there can be many potential improvements in the care delivery process and patient safety through the effective use of an EMR. It is not the time for the industry to be complacent. Hospitals are tasked with the need to do more with less, while also keeping pace with technology and patient expectations. In many hospitals, nurses and clinical staff spend half of their working hours per shift on documentation activities, whereas they should ideally be spending most of their focus on direct patient care. What is the advantage of having expensive EMRs when providers have to note patient vitals and key parameters in some cases still on paper and manually key-in those into the electronic record? Improved care coordination also requires accurate, complete, and automated data capture. Medical device connectivity and interoperability is quickly becoming a top priority at hospitals and in healthcare settings because of the numerous benefits it offers across the care continuum. A well-established device connectivity strategy can help hospitals implement clinical alarms based on early warning scores, automated electronic charting, emergency alert and response systems, virtual intensive care units (ICUs), continuous patient surveillance and remote patient monitoring, medical device asset management, and real-time location solutions. The high-acuity care environment is dynamically changing globally, especially with regard to operating rooms, intensive care units and their workforce. The growing shortfall of intensive care workforce is challenging the ability of hospitals to care for critically ill patients. There is a growing need for intensivists and trained nursing staff to care for critically ill patients in acute care settings. In many countries, a shortfall of intensivists poses a real challenge; there is either a short supply or they are entirely absent, with workloads being shared by non-trained hospital personnel. It is quite evident that expert care from specialists can improve patient outcomes and shorten hospital stays, thereby reducing costs and minimising length of stay and readmissions. As an alternative to critical care delivery models, hospitals can leverage EMRs and medical device connectivity solutions to overcome the shortages of intensivists in the high-acuity care environment. Medical devices compliant with the healthcare enterprise (IHE) patient care device (PCD) regulation can establish connectivity with the enterprise hospital network for sharing patient-generated data. A centralised patient surveillance platform offering end-to-end medical device connectivity acquiring patient data in real time, intelligent clinical alarm systems with advanced analytics, a clinical-decision support system (CDSS) and a virtual ICU solution can address the challenges in the intensive care environment. Bi-directional communication between connected medical devices and clinical information systems (CIS), particularly for smart infusion pumps programming and multi-parameter patient monitoring has proven to prevent adverse events in the high-acuity care environment. A well-integrated system with a centralised clinical dashboard with real-time insights on patients can help intensivists by prioritising patients that require higher levels of care.--BEGIN PROMO--

Research Highlights

Frost & Sullivan’s new research report on the Global Hospital-based Medical Device Connectivity Solutions Market, Forecast to 2022 provides a comprehensive analysis on the global medical device interoperability market with a competitive landscape covering clinical information technology (IT) systems vendors, medical device original equipment manufacturers (OEMs), vendor-agnostic third-party medical device data systems (MDDS) vendors, and healthcare system integrators. Please reach out to us to know more about medical device interoperability solutions and numerous methods to establish connectivity of your medical devices with the hospital network regardless of device types.

Presented Segmentation:

  • Clinical IT Systems Vendors
  • Medical Device OEMs
  • Vendor-Agnostic Connectivity Vendors
  • Healthcare System Integrators

Key Issues Addressed

  • What are the key market trends and industry dynamics in the medical device connectivity market? What is the future potential for medical device connectivity solutions?
  • What is the current market scenario? How much growth is expected? Which are the major market segments? What will be the impact of external trends on each business segment?
  • Who are the major participants in the global market for medical device connectivity? What are their solution offerings, product features and technical specifications?
  • What is driving the market? What are the restraints impacting growth opportunities for medical device connectivity in the global market?
  • What are the important business model considerations for healthcare stakeholders and providers? Are there any unmet customer needs? Is there an untapped opportunity in this market?
  • Are the connectivity solution offered by solution vendors today meeting end-user needs? Does it require additional enhancements to address critical business needs?
Fri, 27 Apr 2018 00:00:00 +0100
Healthcare Innovations in Emerging Economies http://www.frost.com/prod/servlet/sublib/display-report.do?id=D831-01-00-00-00 MedTech markets are among the most competitive markets worldwide, which are largely dominated by large multinational companies offering a wide range of products and solutions for top diseases. Emerging markets are vital to sustainable business growth and performance of top multinational companies, especially due to the huge patient turnover rates across most reputed healthcare facilities. The trend is evident in countries like India, Thailand, Singapore, Israel, Taiwan and Australia where high patient turnover rates are observed across medical imaging centers, operation theatres and outpatient services. This research service focuses on the need for sustainable sourcing of innovations across emerging economies to maintain market leadership and consistent business performance across competitive portfolios. The research service covers a snapshot of current industry scenario, including coverage of market growth, top companies, major drivers and challenges that are challenging the status-quo of companies operating in the emerging market especially, India, China, and Taiwan to name some. The chapters also cover gamechanging technologies and research initiatives that drive business performance in competitive portfolios. Key questions answered in this research service: 1. How the global medtech industry is segmented in terms of growth, technology change, customer segments and competitive scenario? 2. Who are the top competitors within the market, and how are they performing within emerging markets? What are the factors critical to survival of global companies , and their sustainable business growth within emerging economies? 3. Is there a strategic framework to address concerns of stakeholders along the value chain? What are the use cases of applying proprietary in-house data within this framework to aid in our internal decision making process? 4. How is the global technology innovation landscape for medical technologies? Who are the major players in the market? 5. What are the key patent filing trends impacting their competitive performance within the global medtech industry? Fri, 27 Apr 2018 00:00:00 +0100 Recent Advances in Anti-cancer and Antimicrobial Therapies http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-76-00-00 This edition of the Genetic Technology TOE depicts trends across anticancer and antimicrobial therapies. Selected antitumoral and antimicrobial platform technologies including radio-conjugate platforms and checkpoint inhibitor immunotherapies for enhancing targeted therapies, as well as, synthetic macromolecules for addressing multi-drug bacterial resistance have been profiled. The corresponding clinical trials scenario is depicted for Actinium-225-labeled humanized anti-CD33 monoclonal antibody HuM195 and UCART19. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Anti-cancer, antitumoral, antimicrobial, radio-conjugate platform, targeted therapy, cancer immunotherapy, checkpoint inhibitor therapy, synthetic macromolecules, multi-drug resistant bacteria, clinical trial analysis, HuM195, UCART19 Fri, 20 Apr 2018 00:00:00 +0100 Asia-Pacific Healthcare Outlook, 2018 http://www.frost.com/prod/servlet/sublib/display-report.do?id=P9E1-01-00-00-00 The healthcare industry in Asia-Pacific (APAC) is expected to grow at 11.1% in 2018, making it one of the fastest growing regions in the world, as the global healthcare economy averages an annual growth rate of 4.8%. This positive growth is fuelled by increasing adoption of technology, innovative healthcare access programs, and delivery of care outside traditional hospital settings. Frost & Sullivan projects the APAC healthcare market to grow to $517 billion in 2018. For the region, healthcare challenges of access and affordability of new technology demand complex and innovative solutions from all industry stakeholders. Key industry issues that deserve attention include policy innovation, support for new business models, development of patient-focused technology platforms, and the evolving role of consumers in healthcare. These emerging trends create growth opportunities for industry participants including pharmaceuticals, diagnostics, and medical technology manufacturers, digital health vendors, and healthcare service providers. The role of healthcare consumers is changing dramatically in APAC. Digital technology is enabling access to information and care; hence consumers are able to choose where, how, and by whom they would like to be treated. This is changing every business model in the region. With this major industry transition as the background, some of the Growth Opportunities discussed in this year s Outlook cover the following areas: Private Health Insurance Medical Tourism Healthcare Provider Infrastructure Imaging Analytics Patient Monitoring Platforms Mental Health Regenerative Medicine Biosimilars Cloud and AI. An important global trend that is currently missing in APAC is the introduction of value- and outcomes-based payment and reimbursement models. Industry suppliers, including IT vendors, medical technology companies and pharmaceuticals, are partnering with public and private payers to introduce outcomes-based reimbursement models for expensive therapeutic products and services in other parts of the world. In 2018, Japan could be the first in APAC to introduce an outcomes-based reimbursement model for Novartis CAR-T therapy, with China potentially following suit. On the other hand, personalization combined with consumer empowerment will be the key ingredient for disease prevention and patient wellness. Direct-to-consumer gene sequencing is moving toward services and solutions as companies like Prudential, iCarbonX, and Healthi have introduced personalized wellness interventions. On the other hand, companies like Thorne Research and Imagene Labs will make available personalized over-the-counter nutritional supplements and skin care products, respectively, and that too on a subscription model. In a nutshell, 2018 is expected to be the year when APAC truly transforms industry business models, with technology and data transparency being the key enablers. Our outlook discusses the qualitative and quantitative factors driving this transformation. Tue, 3 Apr 2018 00:00:00 +0100